Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402.
about
The Pathophysiological Impact of HLA Class Ia and HLA-G Expression and Regulatory T Cells in Malignant Melanoma: A ReviewHarnessing the Microbiome to Enhance Cancer ImmunotherapyPhase 1 study of OCV-C02, a peptide vaccine consisting of two peptide epitopes for refractory metastatic colorectal cancer.Adjuvants for vaccines to drugs of abuse and addiction.Peptides and peptide conjugates: therapeutics on the upward path.Immune modulation by chemotherapy or immunotherapy to enhance cancer vaccines.Standardized Serum-Free Cryomedia Maintain Peripheral Blood Mononuclear Cell Viability, Recovery, and Antigen-Specific T-Cell Response Compared to Fetal Calf Serum-Based Medium
P2860
Q28080338-6C608B3A-0356-44D1-B6F4-7D5BFB7EA50AQ28088598-72236A8E-B0C3-4768-A4DB-0021401805CCQ33738883-C02D379F-63D6-48AA-9C97-F31EE849A1D4Q35493923-B55E682E-C39F-458A-A5C5-9BBCE15E20D7Q38037191-A010FC10-4438-4F91-8205-23C3CBF91F56Q38161367-9862E121-3722-4E40-ABD0-12E8DEBB5B7DQ38544409-6FED78DB-FCFE-4942-8221-CC491B6FDB28
P2860
Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase I clinical trial of the ...... tide restricted to HLA-A*2402.
@ast
Phase I clinical trial of the ...... tide restricted to HLA-A*2402.
@en
Phase I clinical trial of the ...... tide restricted to HLA-A*2402.
@nl
type
label
Phase I clinical trial of the ...... tide restricted to HLA-A*2402.
@ast
Phase I clinical trial of the ...... tide restricted to HLA-A*2402.
@en
Phase I clinical trial of the ...... tide restricted to HLA-A*2402.
@nl
prefLabel
Phase I clinical trial of the ...... tide restricted to HLA-A*2402.
@ast
Phase I clinical trial of the ...... tide restricted to HLA-A*2402.
@en
Phase I clinical trial of the ...... tide restricted to HLA-A*2402.
@nl
P2093
P2860
P356
P1476
Phase I clinical trial of the ...... tide restricted to HLA-A*2402.
@en
P2093
Akihiko Itoh
Akira Kanamoto
Hideaki Tahara
Marimo Sato-Matsushita
Naoki Oyaizu
Toshiyuki Baba
Yusuke Inoue
Yutaka Kawakami
P2860
P2888
P356
10.1186/1479-5876-8-84
P577
2010-09-16T00:00:00Z